Carla Greenlaw

Learn More
BACKGROUND Chemotherapy-resistant neuroblastoma is a difficult disease to treat with poor survival. OBSERVATIONS We treated a patient with neuroblastoma who had progressed on conventional chemotherapy. This 5-year-old girl with chemotherapy-resistant neuroblastoma developed Chagas disease at the start of salvage chemotherapy for which she was also started(More)
The effectiveness of a community hospital's computerized drug interaction screening system, PADIS (Pharmacy Automated Drug Interaction Screening), with pharmacists evaluating and advising physicians of each drug interaction's potential significance, was evaluated. The study was conducted during a 100-day period on all patients (34,564 patient days) with the(More)
A total parenteral nutrition program in a 635-bed private nonteaching institution which uses the pharmacist as team leader is described. To initiate TPN therapy, the attending physician writes a request for a consulation with the pharmacist. Prior to initiation of TPN therapy, the pharmacist reviews the chart, conducts a physical and nutritional assessment(More)
Reversible acute organic brain syndrome is described in a patient receiving disulfiram, 250 mg daily. Slowing of the electroencephalogram (3 to 4 cycles per second) in the occipital region resolved ten days after discontinuation of disulfiram. Acute organic brain syndrome induced by disulfiram is not rare but is often not correlated, and it should always be(More)
A pharmacy automated drug interaction screening (PADIS) system is described which detects possible drug interactions by screening patient medication profiles. The data base contains approximately 24,000 drug interaction combinations of drugs marketed in the U.S. and also foreign and investigational drugs that have been implicated to cause drug interactions.(More)
A pharmacy program designed to reduce the inappropriate use of aminoglycoside serum assays is described, and the results of an evaluation of the program are reported. If the clinical status of the patient for whom an assay is ordered does not correspond to the indications for the test, a pharmacist calculates predicted aminoglycoside serum levels based on(More)
The cost of operating a computerized drug interaction screening program at a 635-bed private community hospital was studied. Cost data were collected during the development of the Pharmacy Automated Drug Interaction Screening system in 1975 and during a one-year study period, June 1978 to June 1979. The total cost of the interaction screening system was(More)